Literature DB >> 22159905

Two cases of type A infant botulism in Grenoble, France: no honey for infants.

Gautier Hoarau1, Isabelle Pelloux, Armelle Gayot, Isabelle Wroblewski, Michel-Robert Popoff, Christelle Mazuet, Max Maurin, Jacques Croizé.   

Abstract

We report two severe cases of infant botulism diagnosed at Grenoble University Hospital, France, respectively in 2006 and 2009. Both cases were characterized by a delay in diagnosis, severe neurological manifestations and extended period of hospitalization in intensive care unit, but a complete recovery. Infant botulism is a rare but life-threatening disease. It primarily affects infants, and the main risk factor is honey ingestion. Diagnosis should be systematically evoked by pediatricians in infants suffering from constipation, fatigue, muscle weakness, difficult feeding and altered cry, but before the onset of generalized flaccid paralysis, so as to administer specific treatment (BabyBIG®, a human derived botulinum antitoxin) at an early stage of the disease when it is most effective. In conclusion, parents should be aware of the role of honey as a source of spores of Clostridium botulinum and therefore infant botulism in the first year of life.

Entities:  

Mesh:

Year:  2011        PMID: 22159905     DOI: 10.1007/s00431-011-1649-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Infant botulism and honey in Europe: a commentary.

Authors:  Paolo Aureli; Giovanna Franciosa; Lucia Fenicia
Journal:  Pediatr Infect Dis J       Date:  2002-09       Impact factor: 2.129

2.  Infant botulism in Australia: availability of human botulinum antitoxin for treatment.

Authors:  Meryta L A May; Michael A Corkeron; Mark Stretton
Journal:  Med J Aust       Date:  2010-11-15       Impact factor: 7.738

3.  [Infant botulism in France, 1991-2009].

Authors:  L-A King; M-R Popoff; C Mazuet; E Espié; V Vaillant; H de Valk
Journal:  Arch Pediatr       Date:  2010-08-17       Impact factor: 1.180

4.  A six month-old girl with botulism due to honey ingestion.

Authors:  Parviz Vahdani; Farhad Abbasi; Mohammad Reza Adhami Mojarad; Ali Akbar Velayati; Mohammad Reza Boloorsaz; Fariba Musavipour; Golnaz Vahdani
Journal:  Indian J Pathol Microbiol       Date:  2009 Oct-Dec       Impact factor: 0.740

5.  Equine botulinum antitoxin for the treatment of infant botulism.

Authors:  Elida E Vanella de Cuetos; Rafael A Fernandez; María I Bianco; Omar J Sartori; María L Piovano; Carolina Lúquez; Laura I T de Jong
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

Review 6.  Medical treatment for botulism.

Authors:  Colin Chalk; Tim J Benstead; Mark Keezer
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

7.  Report of two unlinked cases of infant botulism in the UK in October 2007.

Authors:  Kathie A Grant; Ijeoma Nwarfor; Obioma Mpamugo; Vina Mithani; Paula Lister; Garth Dixon; Grainne Nixon; Timothy Planche; Max Courtney; Jaime Morgan; Jim McLauchlin
Journal:  J Med Microbiol       Date:  2009-08-06       Impact factor: 2.472

Review 8.  Botulism.

Authors:  Jeremy Sobel
Journal:  Clin Infect Dis       Date:  2005-08-29       Impact factor: 9.079

9.  Human botulism immune globulin for the treatment of infant botulism.

Authors:  Stephen S Arnon; Robert Schechter; Susan E Maslanka; Nicholas P Jewell; Charles L Hatheway
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

10.  Genetic confirmation of identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of infant botulism.

Authors:  J C Suen; C L Hatheway; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more
  2 in total

Review 1.  Human Botulism in France, 1875-2016.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

Review 2.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.